Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,252,839

« Back to Dashboard

Which drugs does patent 7,252,839 protect, and when does it expire?

Patent 7,252,839 protects KYLEENA and SKYLA and is included in two NDAs.

This patent has thirty patent family members in twenty-six countries.

Summary for Patent: 7,252,839

Title:	Delivery system and a manufacturing process of a delivery system
Abstract:	A delivery system including a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, the capsule having at least a first end and a second end. The body construction (7, 12, 34) has at least two locking parts (9, 10), each locking part (9, 10) having at least a first end and a second end, the first end of each locking part (9, 10) having a surface adapted to face and cover one of the at least first and second ends of the capsule (8). The diameter of at least one of the locking parts varies along its length between the first end and the second end, and the capsule (8) is mounted between the at least two locking parts. Also disclosed is a manufacturing process of a delivery system, the system including a body construction and at least one capsule containing a pharmaceutical composition.
Inventor(s):	Hallinen; Esa (Lempaala{umlaut over ( )}, FI), Lyytikainen; Heikki (Naantali, FI), Jarvela; Pentti (Lahti, FI), Kivi; Ilkka (Pirkkala, FI)
Assignee:	Schering Oy (Turku, FI)
Application Number:	10/528,237
Patent Claim Types: see list of patent claims	Composition; Dosage form; Delivery; Process;

Drugs Protected by US Patent 7,252,839

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Bayer Hlthcare	KYLEENA	levonorgestrel	INTRAUTERINE DEVICE;INTRAUTERINE	208224-001	Sep 16, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Bayer Hlthcare	SKYLA	levonorgestrel	INTRAUTERINE DEVICE;INTRAUTERINE	203159-001	Jan 9, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 7,252,839

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	02020869	Sep 18, 2002

PCT Information
PCT Filed	September 04, 2003	PCT Application Number:	PCT/FI03/00647
PCT Publication Date:	April 01, 2004	PCT Publication Number:	WO2004/026196

International Patents Family Members for US Patent 7,252,839

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	387898	➤ Sign Up
Australia	2003258752	➤ Sign Up
Brazil	0314287	➤ Sign Up
Canada	2499187	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.